TRACON Pharmaceuticals and I-Mab Biopharma Reschedule Conference Call to Discuss Strategic Partnerships for Multiple Immuno-Oncology Programs

SAN DIEGO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Due to the United States stock markets being closed on Wednesday, December 5, 2018, for the national day of mourning due to the passing of President ...

TRACON Pharmaceuticals and I-Mab Biopharma to Host Conference Call to Discuss Strategic Partnerships for Multiple Immuno-Oncology Programs

SAN DIEGO, Dec. 03, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...